Nautic Partners is acquiring infusion provider KabaFusion from Novo Holdings for around $2.2 billion, three sources familiar with the situation tell Axios Pro.
Why it matters: There are a lot of other PE-backed infusion companies in market, and this sets an attractive price comp.
